Diabet. Endocrine, nutritional and metabolic diseases
Conditions
Interventions
Intervention 1: Intervention group: blood samples will be taken at the beginning study
measures HBA1C, TG, cholesterol, LDL, HDL, fasting blood suger, CRP, blood pressure and then 4-week intake yogurt probiotics(2.5 % fat), 100g packages three times a day. At the end of the study ,afte
measures HBA1C, TG, cholesterol, LDL, HDL, fasting blood suger, CRP, blood pressure and then 4-week intake usual yogurt(2.5 % fat), 100g packages three times a day. At the end of the study, after 4 w
Intervention group: blood samples will be taken at the beginning study
Control group: blood samples will be taken at the beginning study
Sponsors
Golestan University of Medical Science, Research & Technology
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: people are choosing which cases are active and are cilinic 5 Azar hospital diabetes the last test in case of non-fasting plasma glucose and fasting plasma glucose greater than 110 or greater than 200; more than a year has passed since the diabetes pill Metformin and Glibeclamid consume or use insulin; not suffering from an advanced form of the disease known vital organs and mental disorders; age between 30 to 70 years old and living in Gorgan. Exclusion criteria: Patients who for any reason are excluded during the study
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TG. Timepoint: The beginning of the study, and 4 weeks later. Method of measurement: Taking a blood sample and send to the laboratory.;Cholestrol. Timepoint: The beginning of the study, and 4 weeks later. Method of measurement: Taking a blood sample and send to the laboratory.;HBA1C. Timepoint: The beginning of the study, and 4 weeks later. Method of measurement: Taking a blood sample and send to the laboratory.;LDL. Timepoint: The beginning of the study, and 4 weeks later. Method of measurement: Taking a blood sample and send to the laboratory.;HDL. Timepoint: The beginning of the study, and 4 weeks later. Method of measurement: Taking a blood sample and send to the laboratory.;Fasting Blood Suger. Timepoint: The beginning of the study, and 4 weeks later. Method of measurement: Taking a blood sample and send to the laboratory. | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood Pressure. Timepoint: Before and after study. Method of measurement: Blood pressure device.;CRP. Timepoint: Before and after intervention. Method of measurement: Venous blood samples. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahin.Rezaei
Golestan University of Medical Sciences
Outcome results
None listed